Absher Wealth Management, LLC Novo Nordisk A S Transaction History

Absher Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$103.24 - $121.81 $489,151 - $577,135	-4,738 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$93.1 - $112.54 $137,881 - $166,671	-1,481 Reduced 23.81%	4,738 $526,000
Q4 2021 Jan 18, 2022	SELL	$95.88 - $117.08 $50,241 - $61,349	-524 Reduced 7.77%	6,219 $697,000
Q3 2021 Nov 04, 2021	SELL	$84.42 - $106.62 $95,647 - $120,800	-1,133 Reduced 14.39%	6,743 $647,000
Q2 2021 Aug 03, 2021	BUY	$67.66 - $84.76 $24,357 - $30,513	360 Added 4.79%	7,876 $660,000
Q1 2021 May 07, 2021	BUY	$67.06 - $75.82 $67,194 - $75,971	1,002 Added 15.38%	7,516 $507,000
Q4 2020 Feb 01, 2021	BUY	$63.89 - $73.8 $23,128 - $26,715	362 Added 5.88%	6,514 $455,000
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $2,229 - $2,457	35 Added 0.57%	6,152 $427,000
Q2 2020 Jul 27, 2020	SELL	$58.54 - $67.94 $142,018 - $164,822	-2,426 Reduced 28.4%	6,117 $401,000
Q1 2020 May 01, 2020	BUY	$49.46 - $64.78 $3,363 - $4,405	68 Added 0.8%	8,543 $514,000
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $422,563 - $493,753	8,475 New	8,475 $511,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Absher Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Absher Wealth Management, LLC with notifications on news.